Monday, March 1, 2021
Saturday, February 27, 2021
Don't become one of these people, if you can help it.
Friday, February 19, 2021
Thursday, February 18, 2021
Sunday, February 14, 2021
Saturday, February 13, 2021
Friday, February 12, 2021
Wednesday, February 10, 2021
Saturday, February 6, 2021
Thursday, February 4, 2021
Wednesday, February 3, 2021
Monday, February 1, 2021
Monday, January 25, 2021
Saturday, January 23, 2021
Tuesday, January 12, 2021
Saturday, January 9, 2021
Thursday, January 7, 2021
mRNA Vaccines Might Prove Catastrophic in a Rushed Coronavirus Response
Bombshell primer breaks down the very real risks of this cutting-edge technology
The FDA says Pfizer’s Covid vaccine is safe and effective. But trial participants warn of intense symptoms after second shot
Others experienced headaches and fatigue.
The FDA said that while side effects of the Pfizer vaccine are common, there are "no specific safety concerns identified that would preclude issuance of an EUA."
From what I can tell by casual observation, maybe 10 to 20% of the population doesn't want to take the vaccine.
Ivermectin has antiviral effects against several distinct positive-sense single-strand RNA viruses, including SARS-CoV-2. On 10 April 2020, the FDA issued guidance to not use veterinary-grade ivermectin as treatment for COVID-19 in humans.
Ivermectin inhibits replication of SARS-CoV-2 in monkey kidney cell culture with an IC50 of 2.2 - 2.8 µM, making it a possible candidate for COVID-19 drug repurposing research. The doses used in cell culture would require 104 larger doses in humans based on this data, which does not look promising as an effective treatment for COVID-19. Such high doses of ivermectin are not covered by the current human-use approvals of the drug and could be dangerous, as the likely antiviral mechanism of action is the suppression of a host cellular process, specifically the inhibition of nuclear transport by importin α/β1.
A preprint published in April 2020 claimed benefits of ivermectin in the treatment of COVID-19, but it was a retrospective study based on questionable hospital data from Surgisphere and was withdrawn at the end of May. The preprint led to several government agencies in Latin America recommending ivermectin as a COVID-19 treatment; these recommendations were later denounced by the regional WHO office. On October 12, 2020 Peru withdrew its authorization to use ivermectin and hydroxychloroquine as COVID-19.